Ramegowda Rajagopal, MD
Cardiovascular Disease · Detroit, MINPI 1538131511
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Astellas Pharma US Inc at 56.9% of the total. Reporting peaked in 2019 at $239 and has fallen 87.8% since, to $29 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 14 payments — averaging $36.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$287
- Vanda Pharmaceuticals Inc.$101
- GE HealthCare$37
- Lantheus Medical Imaging, Inc.$23
- Lilly USA, LLC$17
- Amarin Pharma, Inc.$14
- plus $26 from 2 others
What the payments were for
- Food & beverage$21743%
- Education$28757%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $287 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| GE HealthCare | 2 | $37 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
How this compares
$504 in reported general payments places this provider in the 25th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Detroit
- Pedro Villablanca SpinettoDetroit$620K
- Wayne WeaverDetroit$340K
- Brian OneillDetroit$250K
- Karthikeyan AnanthasubramaniamDetroit$112K
- Gerald KoenigDetroit$96K
- David LanfearDetroit$82K
- Celeste WilliamsDetroit$70K
- Mahir ElderDetroit$68K
- Cori RussellDetroit$67K
- Pedro Engel GonzalezDetroit$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.